Metraipolis › archive › dc_e6630e5ecf56
Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppression — Europe PMC PMID:41372991
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41372991
- DOI
- 10.1186/s40364-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T17:35:48.123Z
- SHA-256 of the archived text
49dd8b22c746d444976d2c8426f6f65798a4dc318d6c5beba5a757b7c17bc3c8- Stable URL of this page
https://metraipolis.com/documento/dc_e6630e5ecf56
How to cite
Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppression — Europe PMC PMID:41372991 — Europe PMC (en), https://europepmc.org/article/MED/41372991 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e6630e5ecf56 (Metraipolis archive dc_e6630e5ecf56, sha256 49dd8b22c746d444976d2c8426f6f65798a4dc318d6c5beba5a757b7c17bc3c8)
BibTeX
@misc{dce6630e5ecf56,
title = {Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppression — Europe PMC PMID:41372991},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41372991},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e6630e5ecf56; sha256 49dd8b22c746d444976d2c8426f6f65798a4dc318d6c5beba5a757b7c17bc3c8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41372991. Agents can read the archived copy with the MCP tool read_document.